Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles.
about
Recent progress in adjuvant discovery for peptide-based subunit vaccinesShigella flexneri 3a outer membrane protein C epitope is recognized by human umbilical cord sera and associated with protective activitySynthesis and characterisation of self-assembled and self-adjuvanting asymmetric multi-epitope lipopeptides of ovalbumin.A Multiple Antigenic Peptide Mimicking Peptidoglycan Induced T Cell Responses to Protect Mice from Systemic Infection with Staphylococcus aureus.Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges.Peptides for immunological purposes: design, strategies and applications.Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.Peptide conjugation via CuAAC 'click' chemistry.Recent advances in peptide-based subunit nanovaccines.Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.Strategic role of selected noble metal nanoparticles in medicine.Fungi as an efficient mycosystem for the synthesis of metal nanoparticles: progress and key aspects of research.The role of nanotechnology in control of human diseases: perspectives in ocular surface diseases.Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines.In Situ Capture of Bacterial Toxins for Antivirulence Vaccination.Short peptide epitope design from hantaviruses causing HFRS.Immunoprophylaxis of multi-antigen peptide (MAP) vaccine for human lymphatic filariasis.
P2860
Q34033780-0D2D3007-57E9-4DE8-A17D-757BED2B933FQ34935297-DD68642E-942B-4B5E-9D09-9B9FC3554065Q35423378-04450802-79BD-41E8-BC3B-674D2493821CQ35758457-F8000F54-BE74-4D01-AED4-04B61198A15EQ37277330-9C6F0278-E92D-4AFB-8B83-2E5B1F1B941CQ38112633-24ABF807-7E1D-49B3-82EB-44D06B0FD3C6Q38151736-28C677D2-68AD-46B2-AD0E-4DA152D34D0DQ38166894-725701F1-AD57-4210-9368-21B61C77381AQ38296076-2188F3A5-3F53-4C84-8665-1FE3B6596AA1Q38461061-DB47D6DC-795A-4293-9D43-8A016CE67A32Q38531727-CA2C4F49-7A33-4829-8601-1DBA26A7FC0BQ38545443-6C1D43C6-9A24-4628-B535-E5D4925C90BEQ38550131-5D124E4B-D8A8-4F55-B9D8-067D8408642AQ38680785-73DA5035-D092-4A5A-B3BC-6133ED6AAFECQ40155457-846C622E-D324-4772-9F24-44905ECA7430Q41698233-7BF2ECDE-FA7E-4869-B875-672791518E02Q50863204-45E09CB7-4AA8-4073-9121-A532AF8CA78D
P2860
Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current status of multiple ant ...... c and inorganic nanoparticles.
@en
Current status of multiple ant ...... c and inorganic nanoparticles.
@nl
type
label
Current status of multiple ant ...... c and inorganic nanoparticles.
@en
Current status of multiple ant ...... c and inorganic nanoparticles.
@nl
prefLabel
Current status of multiple ant ...... c and inorganic nanoparticles.
@en
Current status of multiple ant ...... c and inorganic nanoparticles.
@nl
P2860
P356
P1476
Current status of multiple ant ...... c and inorganic nanoparticles.
@en
P2093
Hiroaki Taguchi
Yoshio Fujita
P2860
P2888
P356
10.1186/1752-153X-5-48
P577
2011-08-23T00:00:00Z
P5875
P6179
1019917069